| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 10/20/2004 | CN1538959A Fused-polycyclic compounds |
| 10/20/2004 | CN1538956A Spiro compounds |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1538835A Ophthalmic depot fomulations for periocular or conjunctival administration |
| 10/20/2004 | CN1537531A Celecoxib compositions |
| 10/20/2004 | CN1537519A Golden eye shade cover, and its making method |
| 10/20/2004 | CN1171997C Modified TLE-2-receptor ligands |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171883C Nonsteroidal antiinflammatories |
| 10/20/2004 | CN1171610C Traditional Chinese medcine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method |
| 10/20/2004 | CN1171593C Embedded musk and its preparing process |
| 10/19/2004 | US6806370 NK-1 receptor active amine oxide prodrugs |
| 10/19/2004 | US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 10/19/2004 | US6806268 Method for treating glaucoma V |
| 10/19/2004 | US6806243 Ophthalmic solution and contact lens solution |
| 10/14/2004 | WO2004087763A1 Modified antibody against cd22 and utilization thereof |
| 10/14/2004 | WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 10/14/2004 | WO2004087188A1 Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
| 10/14/2004 | WO2004087138A1 Method for treating vascular hyperpermeable disease |
| 10/14/2004 | WO2004087125A1 Amino acid derivatives as inhibitors of mammalian sodium channels |
| 10/14/2004 | WO2004087103A1 Ophthalmic drug delivery system using polymer micell |
| 10/14/2004 | WO2004024190A3 Recombinant lentivirale vector pseudotyped with the hemagglutinin protein for gene transfer into the retina |
| 10/14/2004 | WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 10/14/2004 | US20040204590 Ep4 receptor agonist, compositions and methods thereof |
| 10/14/2004 | US20040204465 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 10/14/2004 | US20040204437 Substituted arylamine derivatives and methods of use |
| 10/14/2004 | US20040204425 Sodium channel blockers |
| 10/14/2004 | US20040204424 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 10/14/2004 | US20040204418 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 10/14/2004 | US20040204408 Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 10/14/2004 | US20040204399 Aerosolized decongestants for the treatment of sinusitis |
| 10/14/2004 | US20040204364 Peptides for activation and inhibition of deltaPKC |
| 10/14/2004 | US20040204350 Disease- associated protein |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | DE10313341A1 Verwendung von proNGF, insbesondere zur Wundheilung der Cornea und der Haut Use of proNGF, especially for wound healing of the cornea and skin |
| 10/14/2004 | CA2520957A1 Method for treating vascular hyperpermeable disease |
| 10/14/2004 | CA2520580A1 Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
| 10/14/2004 | CA2520525A1 Ophthalmic drug delivery system using polymer micelle |
| 10/13/2004 | EP1466891A1 Carboxylic acid derivative |
| 10/13/2004 | EP1466615A1 Pharmaceutical composition |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465900A1 Rho-kinase inhibitors |
| 10/13/2004 | EP1465886A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465659A2 Use of a novel cell surface protease from group b streptococcus |
| 10/13/2004 | EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1465619A1 Suppression of cartilage degradation via the estrogen receptor |
| 10/13/2004 | EP1465616A1 Treatment of statin side effects using uridine derivatives |
| 10/13/2004 | EP1465596A1 Polymeric gel system for the controlled delivery of codrugs |
| 10/13/2004 | EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 10/13/2004 | EP1280820B1 Anti-inflammatory compounds and uses thereof |
| 10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
| 10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 10/13/2004 | EP1161245B1 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 10/13/2004 | CN2647308Y Vision intensifying medical film |
| 10/13/2004 | CN1537111A Urea substituted imidazoquinolines |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1536998A Integrin inhibitors for treatment of eye diseases |
| 10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 10/13/2004 | CN1535983A Blood vessel generating inhibitor |
| 10/13/2004 | CN1170931C Vasculogenesis correlation molecule |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 10/13/2004 | CN1170585C Remedies for nervous diseases |
| 10/13/2004 | CN1170532C 2-aminotetralin derivatives for therapy of glaucoma |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | CA2146006C Use of ergoline derivatives for the treatment of glaucoma |
| 10/07/2004 | WO2004085431A1 Prostaglandin analogs as ep4 receptor antagonists |
| 10/07/2004 | WO2004085430A1 Prostaglandin analogs as ep4 receptor agonists |
| 10/07/2004 | WO2004085388A2 Cyclic protein tyrosine kinase inhibitors |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084929A1 USE OF proNGF, IN PARTICULAR FOR HEALING WOUNDS OF THE CORNEA AND THE SKIN |
| 10/07/2004 | WO2004084903A1 Use of a trioxopyrimidine for the treatment and prevention of ocular pathologic angiogenesis |
| 10/07/2004 | WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 10/07/2004 | WO2004084877A1 Composition for ophthalmic use |
| 10/07/2004 | WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use |
| 10/07/2004 | WO2004004757A8 Treatment for eye disorder |
| 10/07/2004 | WO2003099195A3 Immunomodulatory compounds and methods of use thereof |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198834 Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 10/07/2004 | US20040198832 Compositions and methods for treating amyloidosis |
| 10/07/2004 | US20040198829 Adjust transportation of active material to eye |
| 10/07/2004 | US20040198803 Method for reducing intraocular pressure using indole derivatives |
| 10/07/2004 | US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198763 Usign tacrolimus; eye drops |
| 10/07/2004 | US20040198757 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/07/2004 | US20040198749 Methods of using sodium channel blockers |
| 10/07/2004 | US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders |